PABLO
MARTÍN-RABADÁN CABALLERO
Investigador en el periodo 2011-2016
Jesús
Guinea
Publicaciones en las que colabora con Jesús Guinea (11)
2023
-
A mutation responsible for impaired detection by the Xpert SARS-CoV-2 assay independently emerged in different lineages during the SARS-CoV-2 pandemic
BMC Microbiology, Vol. 23, Núm. 1
-
First Report of Neocucurbitaria unguis-hominis Keratitis
Journal of Fungi, Vol. 9, Núm. 1
2022
-
Nosocomial Transmission of SARS-CoV-2 Involving Vaccinated Health Care Workers
Microbiology Spectrum, Vol. 10, Núm. 1
-
ΔF659 and F659S substitutions at the HS1 of FKS2 gene, along with E655A and W715L upstream and downstream substitutions, correlate with high ibrexafungerp MICs against Candida glabrata
Clinical Microbiology and Infection, Vol. 28, Núm. 8, pp. 1154.e5-1154.e8
2021
-
Antifungal susceptibility testing identifies the abdominal cavity as a source of candida glabrata-resistant isolates
Antimicrobial Agents and Chemotherapy, Vol. 65, Núm. 12
2020
-
Susceptibility of uncommon Candida species to systemic antifungals by the EUCAST methodology
Medical mycology, Vol. 58, Núm. 6, pp. 848-851
2019
-
Fatal disseminated infection by Gymnascella hyalinospora in a heart transplant recipient
Transplant Infectious Disease, Vol. 21, Núm. 5
2017
-
The misleading effect of serum galactomannan testing in high-risk haematology patients receiving prophylaxis with micafungin
Clinical Microbiology and Infection, Vol. 23, Núm. 12, pp. 1000.e1-1000.e4
2014
-
Is catheter-related candidemia a polyclonal infection?
Medical Mycology
-
Is it feasible to diagnose catheter-related candidemia without catheter withdrawal?
Medical Mycology, Vol. 52, Núm. 5, pp. 489-495
2009
-
Is Candida colonization of central vascular catheters in non-candidemic, non-neutropenic patients an indication for antifungals?
Intensive Care Medicine, Vol. 35, Núm. 4, pp. 707-712